Posters

Filters

Clear Filters
All Days Sun, Sep 27 Mon, Sep 28 Tue, Sep 29

Sunday, September 27

3:00 PM - 4:00 PM ET

2172 - Tile-Based Radiation Therapy for Upfront Treatment of Grade 4 Gliomas in Patients =70 Years and/or Low KPS: Prospective Multi-Institutional Outcomes
Speaker: Peach, Matthew, MD, MB, PhD - ECU Brody School of Medicine, Greenville, NC
3:00 PM - 4:00 PM ET

2173 - GDPD5-CD55-EGFR Competitive Binding Axis Regulates Radioresistance and Lipid Accumulation in Rectal Cancer
Speaker: Peng, Qiliang - Institute of Radiotherapy & Oncology,The Second Affiliated Hospital of Soochow University, Suzhou
3:00 PM - 4:00 PM ET

2174 - Baseline and Time Dependent Predictors of Worsened Quality of Life, Symptoms of Depression, Anxiety, and Self-Reported Cognition: A Secondary Analysis of the ATHENA Trial
Speaker: Perlow, Haley, MD - Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland, OH
3:00 PM - 4:00 PM ET

2175 - Predictors of Toxicity after Re-Irradiation for Recurrent Grade 3-4 Glioma: A Multi-Institutional Analysis
Speaker: Petersen, John, DO - Wake Forest Baptist Medical Center, Winston Salem, NC
3:00 PM - 4:00 PM ET

2176 - ICON-RT: Intracranial CONsolidation and Deferral of Radiation Therapy in Patients Receiving Approved CNS-Active Systemic Therapeutics
Speaker: Pike, Luke, MD, DPhil - Memorial Sloan Kettering Cancer Center, New York, New York
3:00 PM - 4:00 PM ET

2177 - Are Late Complications Emerging In Patients Treated with Stereotactic MR-Guided Adaptive Radiation Therapy (SMART) for Pancreatic Cancer?
Speaker: Pilarski, Sarah, BS - Michigan State University College of Human Medicine, East Lansing, MI
3:00 PM - 4:00 PM ET

2178 - Pilot Study of Respiratory-Gated Stereotactic Body Radiation Therapy for Previously Treated Borderline Resectable, Unresectable, or Recurrent/Residual Adenocarcinoma of the Pancreas or Periampullary Region
Speaker: Prabhu, Arpan, MD - University of Arkansas for Medical Sciences, Little Rock, AR
3:00 PM - 4:00 PM ET

2179 - Uncovering Tumor Heterogeneity Captured by MRI-Based Radiomic Features across Clinical and Outcome Subgroups in Pancreatic Ductal Adenocarcinoma
Speaker: Pyakurel, Uttam, PhD - UCLA David Geffen School of Medicine/UCLA Medical Center, Los Angeles, CA
3:00 PM - 4:00 PM ET

2180 - Outcomes Following Stereotactic Body Radiotherapy (SBRT) for Melanoma Spine Metastases
Speaker: Qazi, Maleeha, MD, PhD - University of Toronto, Toronto, ON
3:00 PM - 4:00 PM ET

2181 - Three Treatment Approaches for Locally Advanced Rectal Cancer: Total Neoadjuvant Therapy, Preoperative Chemoradiotherapy, and Postoperative Chemoradiotherapy - A Systematic Review and Network Meta-Analysis
Speaker: Qixinya, Xinya - Peking Union Medical College, Beijing, chaoyang
3:00 PM - 4:00 PM ET

2182 - Integration of Temporal and Spatial Proton Modulation: Dosimetric Feasibility of Pulsed Dose Rate Spot-Scanning Proton Arc Therapy for Dose Escalated Treatment of Newly Diagnosed Glioblastoma
Speaker: Ramdas, Yastira, MD - University of Witwatersrand, Sandton
3:00 PM - 4:00 PM ET

2183 - Impact of Gross Tumor Volume (GTV) and Effective Uniform Dose (EUD) on Clinical Outcomes after SBRT for Hepatocellular Carcinoma (HCC)
Speaker: Ramkissoon, Avinash, MD, MPH - University of Pennsylvania Radiation Oncology, Philadelphia, PA